je.st
news
Xspray Microparticles AB Announces Positive Phase I Data for HyNap Nilotinib
2014-05-09 06:30:00| Appliances - Topix.net
May 8, 2014. XSpray Microparticles AB today announced that its proprietary HyNapa formulation of nilotinib demonstrated significantly improved uptake and reduced food interaction in a Phase I clinical trial compared to previously reported data for the commercial available formulation of nilotinib.
Tags: data
positive
phase
announces
Category:Consumer Goods and Services